The bladder-cancer drugmaker's sales jumped 53%, and a key trial hit its goal, yet the stock tumbled. The numbers behind the drop tell investors what to watch next.
Organigram is valuing Aurora Cannabis more highly than Curleaf, but that doesn't mean it's the best option for shareholders in the long run.
SMR stocks are getting hammered alongside AI stocks.
It wasn't only Halloween that had investors scared in October.
Nvidia's board of directors is launching an investigation into whether CEO Jensen Huang was the target of a "foreign intelligence effort."
More money now could come at a cost later.
Trading activity implies a 70% probability that the federal funds rate will be higher before year-end.
Monero's recent success is happening as regulators are trying to ban it.
Nvidia stock fell after the news.
These three brands keep winning customers even as their stocks slump, setting up better prospects for returns.
The mREIT's new buyback plan probably won't solve its near-term challenges.
SpaceX is currently trading below its IPO price despite posting blowout earnings results.
Nvidia CEO Jensen Huang is in hot water after admitting an affair with a suspected Chinese spy.
Star the stocks you care about and follow their prices and news in one place.
Start your WatchlistSign in to follow the wire, save stories and manage your plan.
Continue with GoogleBy continuing you agree to our Terms and Privacy Policy.
